Page last updated: 2024-09-04

abiraterone and er-086526

abiraterone has been researched along with er-086526 in 1 studies

Compound Research Comparison

Studies (abiraterone)	Trials (abiraterone)	Recent Studies (post-2010) (abiraterone)	Studies (er-086526)	Trials (er-086526)	Recent Studies (post-2010) (er-086526)
942	97	854	567	113	517

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albiges, L; Blesius, A; de La Motte Rouge, T; Escudier, B; Fizazi, K; Gross-Goupil, M; Loriot, Y; Massard, C	1

Other Studies

1 other study(ies) available for abiraterone and er-086526

Article	Year
[New drugs in metastatic castration-resistant prostate cancer]. Bulletin du cancer, 2010, Volume: 97, Issue:1 Topics: Androgen Antagonists; Androstenes; Androstenols; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Bone Neoplasms; Castration; Denosumab; Epothilones; ErbB Receptors; Furans; Humans; Immunotherapy; Ketones; Male; Orchiectomy; Prostatic Neoplasms; Pyrrolidines; RANK Ligand	2010

Article

Year

[New drugs in metastatic castration-resistant prostate cancer].

Bulletin du cancer, 2010, Volume: 97, Issue:1

Topics: Androgen Antagonists; Androstenes; Androstenols; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Bone Neoplasms; Castration; Denosumab; Epothilones; ErbB Receptors; Furans; Humans; Immunotherapy; Ketones; Male; Orchiectomy; Prostatic Neoplasms; Pyrrolidines; RANK Ligand

2010